Search Results - "Schmults, Chrysalyne"

Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging by Que, Syril Keena T, Zwald, Fiona O, Schmults, Chrysalyne D

“…Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous epithelium, represents 20% to 50% of skin cancers. Although the majority of…”
Get full text

Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma by Ruiz, Emily Stamell, Karia, Pritesh S, Besaw, Robert, Schmults, Chrysalyne D

“…Brigham and Women's tumor classification (BWH) better predicts poor outcomes than American Joint Committee on Cancer (AJCC) 7th edition (AJCC 7). AJCC 8th…”
Get more information

Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors by Que, Syril Keena T, Zwald, Fiona O, Schmults, Chrysalyne D

“…While the majority of cutaneous squamous cell carcinomas (cSCCs) can be treated surgically, the additional work-up and treatments indicated for high-risk cSCC…”
Get full text

Field cancerization: Definition, epidemiology, risk factors, and outcomes by Willenbrink, Tyler J., Ruiz, Emily S., Cornejo, Christine M., Schmults, Chrysalyne D., Arron, Sarah T., Jambusaria-Pahlajani, Anokhi

“…Field cancerization was first described in 1953 when pathologic atypia was identified in clinically normal tissue surrounding oropharyngeal carcinomas. The…”
Get full text

Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study by Schmults, Chrysalyne D, Karia, Pritesh S, Carter, Joi B, Han, Jiali, Qureshi, Abrar A

“…Although most cases of cutaneous squamous cell carcinoma (CSCC) are easily cured with surgery or ablation, a subset of these tumors recur, metastasize, and…”
Get more information

Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma by Karia, Pritesh S, Jambusaria-Pahlajani, Anokhi, Harrington, David P, Murphy, George F, Qureshi, Abrar A, Schmults, Chrysalyne D

“…To compare American Joint Committee on Cancer (AJCC), International Union Against Cancer (UICC), and Brigham and Women's Hospital (BWH) tumor (T) staging…”
Get full text

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial by Migden, Michael R, Khushalani, Nikhil I, Chang, Anne Lynn S, Lewis, Karl D, Schmults, Chrysalyne D, Hernandez-Aya, Leonel, Meier, Friedegund, Schadendorf, Dirk, Guminski, Alexander, Hauschild, Axel, Wong, Deborah J, Daniels, Gregory A, Berking, Carola, Jankovic, Vladimir, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Fury, Matthew G, Rischin, Danny

“…Cemiplimab has shown substantial antitumour activity in patients with metastatic cutaneous squamous cell carcinoma. Patients with locally advanced cutaneous…”
Get full text

Perioperative imaging for high-stage cutaneous squamous cell carcinoma helps guide management in nearly a third of cases: A single-institution retrospective cohort by Gibson, Frederick Thomas, Murad, Fadi, Granger, Emily, Schmults, Chrysalyne D., Ruiz, Emily Stamell

Get full text

Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual by Karia, Pritesh S, Morgan, Frederick C, Califano, Joseph A, Schmults, Chrysalyne D

“…Previous studies have shown that the AJCC Cancer Staging Manual, 7th edition (AJCC 7), tumor classification for cutaneous squamous cell carcinoma (CSCC) failed…”
Get more information

Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data by Karia, Pritesh S, Morgan, Frederick C, Ruiz, Emily Stamell, Schmults, Chrysalyne D

“…Perineural invasion (PNI) in cutaneous squamous cell carcinoma (CSCC) has been associated with an increased risk of poor outcomes. Patients with PNI may…”
Get more information

Reply to “Rational radiotherapy: The role in node-negative squamous cell carcinoma” by Ruiz, Emily Stamell, Koyfman, Shlomo A., Schmults, Chrysalyne D.

Get full text

Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter by Morgan, Frederick C., Ruiz, Emily Stamell, Karia, Pritesh S., Besaw, Robert J., Neel, Victor A., Schmults, Chrysalyne D.

“…Basal cell carcinoma (BCC) recurrence and metastatic rates are known to be very low. The risk factors for these rare outcomes are subsequently not well…”
Get full text

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma by Migden, Michael R, Rischin, Danny, Schmults, Chrysalyne D, Guminski, Alexander, Hauschild, Axel, Lewis, Karl D, Chung, Christine H, Hernandez-Aya, Leonel, Lim, Annette M, Chang, Anne Lynn S, Rabinowits, Guilherme, Thai, Alesha A, Dunn, Lara A, Hughes, Brett G.M, Khushalani, Nikhil I, Modi, Badri, Schadendorf, Dirk, Gao, Bo, Seebach, Frank, Li, Siyu, Li, Jingjin, Mathias, Melissa, Booth, Jocelyn, Mohan, Kosalai, Stankevich, Elizabeth, Babiker, Hani M, Brana, Irene, Gil-Martin, Marta, Homsi, Jade, Johnson, Melissa L, Moreno, Victor, Niu, Jiaxin, Owonikoko, Taofeek K, Papadopoulos, Kyriakos P, Yancopoulos, George D, Lowy, Israel, Fury, Matthew G

“…Among patients with advanced cutaneous squamous-cell carcinoma, the PD-1 inhibitor cemiplimab induced a response in approximately half the patients and was…”
Get full text

Field cancerization: Treatment by Cornejo, Christine M., Jambusaria-Pahlajani, Anokhi, Willenbrink, Tyler J., Schmults, Chrysalyne D., Arron, Sarah T., Ruiz, Emily S.

“…The goal of field cancerization treatment is to reduce the risk of developing keratinocyte carcinoma. Selecting the appropriate therapy depends on the degree…”
Get full text

Improved Margin Control of Microcystic Adnexal Carcinoma After Mohs Micrographic Surgery Compared With Wide Local Excision by Yerneni, Sharmitha, Murad, Fadi, Schmults, Chrysalyne D., Ruiz, Emily S.

“…Microcystic adnexal carcinoma (MAC) is a locally aggressive and deeply infiltrative cutaneous tumor primarily treated with excision; however, there are limited…”
Get full text

Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system by Jambusaria-Pahlajani, Anokhi, Kanetsky, Peter A, Karia, Pritesh S, Hwang, Wei-Ting, Gelfand, Joel M, Whalen, Faith M, Elenitsas, Rosalie, Xu, Xiaowei, Schmults, Chrysalyne D

“…This study proposes an alternative tumor staging system for cutaneous squamous cell carcinoma (CSCC) that more precisely defines the small subset of tumors…”
Get more information

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI) by Hanna, Glenn J., Ruiz, Emily S., LeBoeuf, Nicole R., Thakuria, Manisha, Schmults, Chrysalyne D., Decaprio, James A., Silk, Ann W.

“…Background Immunotherapy has revolutionised the treatment of advanced cutaneous squamous cell carcinoma (cSCC). It is important to understand both safety and…”
Get full text

A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change by Liang, Christine A., MD, Jambusaria-Pahlajani, Anokhi, MD, MSCE, Karia, Pritesh S., MPH, Elenitsas, Rosalie, MD, Zhang, Paul D., MD, Schmults, Chrysalyne D., MD, MSCE

“…Background To our knowledge, no systematic review of dermatofibrosarcoma protuberans (DFSP) outcomes based on the presence or absence of fibrosarcomatous (FS)…”
Get full text

Sex Influences Outcomes in Basal Cell Carcinoma by Shaughnessy, Michael, Murad, Fadi, Morgan, Frederick C, Schmults, Chrysalyne D, Ruiz, Emily Stamell

Get full text

Efficacy of Liposomal Bupivacaine for Pain Control After Large, Complex Mohs Resections: A Matched Cohort Study by Chang, Michael S., Murad, Fadi, Schmults, Chrysalyne D.

Get full text